Survey of US adults finds skepticism about Apple and Google's COVID-19 contact tracing efforts, with smartphone owners split 50-50 on whether they would use it
Nearly 3 in 5 Americans say they are either unable or unwilling to use the infection-alert apps under development by Google and Apple …
Context & Ripple Effects
This survey lands at peak momentum for the dozens of smartphone tracking apps being built to contain the pandemic — weeks before Apple and Google ship the Exposure Notification API that most US state efforts would come to depend on. Its core finding, nearly 3 in 5 Americans unable or unwilling to use the apps and smartphone owners split 50-50, quantifies the demand-side problem the supply side was racing past.
It also prefigures a Pew survey days later showing 60% of Americans think tracing tech won't make much difference — two independent polls converging on the same skepticism before a single state app had shipped at scale.
First-order effects
- Apple and Google built an opt-in system whose value scales with participation; a 50-50 willingness rate caps its reach no matter how many states build on the API.
- State health agencies planning apps inherit an adoption problem engineering cannot solve — the resistance documented here is to the concept of phone-based tracing, not to any specific implementation.
Second-order effects
- States read the same signal and act on it: most retreat from their earlier interest, and by November only fourteen states plus DC have released apps, with adoption weakest where COVID-19 response has been politicized.
- Vendors behind the dozens of bespoke tracking apps face consolidation pressure as governments converge on the Apple-Google API rather than proprietary alternatives, thinning the market for standalone solutions.
Third-order effects
- The episode stands as an early test of trust as public-health infrastructure: a late-2021 trust survey still puts Google at 48% and Apple at 44% among US internet users, suggesting the deficit that stalled exposure notifications persisted after the acute phase passed.
- If the pattern holds, government programs routed through consumer platforms will be judged by the platforms' reputations first — pushing future public-sector deployments toward consent designs built for skepticism rather than assuming goodwill.
The trend: US digital contact tracing became the clearest early test of whether public-health infrastructure can run through consumer platforms, and the trust deficit it exposed outlasted the pandemic itself.